Loading insider details...
Beta
Latest Form 4 (Sep 28, 2026): Grant/Award of 2,110 LXEO shares, $5.6K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Sep 28, 2026 | Lexeo Therapeutics, Inc. (LXEO) | Grant/Award | 2,110 | $5.6K |
| Aug 19, 2026 | Lexeo Therapeutics, Inc. (LXEO) | Sale | 1,304 | $6.5K |
| Jul 1, 2026 | Lexeo Therapeutics, Inc. (LXEO) | Grant/Award | 12,060 | n/a |
| May 20, 2026 | Lexeo Therapeutics, Inc. (LXEO) | Sale | 1,302 | $6.6K |
| Mar 18, 2026 | Lexeo Therapeutics, Inc. (LXEO) | Grant/Award | 5,930 | $15.7K |
| Feb 20, 2026 | Lexeo Therapeutics, Inc. (LXEO) | Sale | 3,016 | $19.3K |
| Feb 6, 2026 | Lexeo Therapeutics, Inc. (LXEO) | Grant/Award | 65,000 | n/a |
| Nov 20, 2025 | Lexeo Therapeutics, Inc. (LXEO) | Sale | 721 | $6.7K |
| Oct 17, 2025 | Lexeo Therapeutics, Inc. (LXEO) | Grant/Award | 5,940 | n/a |
| Aug 20, 2025 | Lexeo Therapeutics, Inc. (LXEO) | Sale | 2,848 | $13.3K |